Rubric Capital Management LP, 10% Owner at TherapeuticsMD, Inc. (TXMD), bought 7,000 shares at $1.00 ($7K) on 2022-10-28, disclosed to the SEC on 2022-10-31.
Open-market purchase of $7k TXMD by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| Filing → |
| TXMD | SELL | 2023-01-03 | $39K | — | Filing → |
| TXMD | BUY | 2022-12-12 | $181K | — | Filing → |
| TXMD | BUY | 2022-10-03 | $7K | — | Filing → |